Simplex Trading’s Impax Laboratories, Inc. IPXL Stock Holding History

Simplex Trading’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,708	Closed	-$243K	–	7162
2017 Q2	$204K	Sell	12,708 -29,042	-70%	-$429K	0.01%	1189
2017 Q1	$528K	Buy	41,750 +35,529	+571%	+$429K	0.02%	649
2016 Q4	$82K	Buy	6,221 +287	+5%	+$4.91K	﹤0.01%	1717
2016 Q3	$140K	Buy	+5,934	New	+$159K	0.01%	1293
2016 Q2	–	Sell	-4,550	Closed	-$148K	–	6866
2016 Q1	$145K	Buy	+4,550	New	+$160K	0.01%	1074
2015 Q4	–	Sell	-1,675	Closed	-$66.9K	–	6604
2015 Q3	$58K	Buy	+1,675	New	+$75.5K	﹤0.01%	1868
2015 Q2	–	Sell	-3,024	Closed	-$144K	–	6247
2015 Q1	$141K	Buy	+3,024	New	+$120K	0.02%	890

Simplex Trading's IPXL Position: Q3 2017 in Review

Simplex Trading sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 12,708 shares — an estimated $243K sold.

Simplex Trading first reported a position in IPXL in Q1 2015 and held it in 7 quarters. The position peaked at $528K in Q1 2017. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

Simplex Trading reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
Simplex Trading sold 12,708 Impax Laboratories, Inc. shares in Q3 2017, an estimated $243K.
Simplex Trading first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 7 quarters.
Simplex Trading's Impax Laboratories, Inc. position peaked at $528K in Q1 2017.
189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Simplex Trading's 13F filing for Q3 2017, filed 25 Oct 2017.